. (. Jopl#, 0!2(6)$+#)610! :)I, )#.,#&! ! 71(2.1)).!)#! $.42+1)).! ! 7)'62,+,!2(6)$+#)610! 9)',+(',&!6$%%42+1)).! ! M666#)2(B,#$+(@,! 32)',#42)%,61#(+(&! ' !"#"()*%+)$+#)610!)#!B$+! $--4'42$+()%! D0&2(6(.,'($! 9)',+(',&!, pp.42610-42617

K. $. Dekker, J. Visser, M. Bouter, L. Stehouwer, C. Yudkin et al., Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels: the Hoorn study, Diabetes Care, vol.27, issue.1, pp.372-377, 2004.

B. Antuna-puente, B. Feve, S. Fellahi, and J. Bastard, Adipokines: The missing link between insulin resistance and obesity, Diabetes & Metabolism, vol.34, issue.1, pp.2-11, 2008.
DOI : 10.1016/j.diabet.2007.09.004

A. Garg and A. Agarwal, Lipodystrophies: Disorders of adipose tissue biology, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol.1791, issue.6, pp.507-513, 2009.
DOI : 10.1016/j.bbalip.2008.12.014

J. Capeau, J. Magré, O. Lascols, M. Caron, V. Béréziat et al., Diseases of adipose tissue: genetic and acquired lipodystrophies, Biochemical Society Transactions, vol.33, issue.5, pp.1073-1077, 2005.
DOI : 10.1042/BST0331073

URL : https://hal.archives-ouvertes.fr/inserm-00848148

A. Garg, Acquired and Inherited Lipodystrophies, New England Journal of Medicine, vol.350, issue.12, pp.1220-1234, 2004.
DOI : 10.1056/NEJMra025261

R. Hegele, T. Joy, S. Al-attar, and B. Rutt, Thematic review series: Adipocyte Biology. Lipodystrophies: windows on adipose biology and metabolism, The Journal of Lipid Research, vol.48, issue.7, pp.1433-1444, 2007.
DOI : 10.1194/jlr.R700004-JLR200

R. Semple, E. Cochran, M. Soos, K. Burling, D. Savage et al., Plasma Adiponectin as a Marker of Insulin Receptor Dysfunction: Clinical utility in severe insulin resistance, Diabetes Care, vol.31, issue.5, pp.977-979, 2008.
DOI : 10.2337/dc07-2194

A. Decaudain, M. Vantyghem, B. Guerci, A. Hecart, M. Auclair et al., Mutations in Patients with Severe Metabolic Syndrome, The Journal of Clinical Endocrinology & Metabolism, vol.92, issue.12, pp.4835-4844, 2007.
DOI : 10.1210/jc.2007-0654

R. Semple, A. Sleigh, P. Murgatroyd, C. Adams, L. Bluck et al., Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis, Journal of Clinical Investigation, vol.119, pp.315-322, 2009.
DOI : 10.1172/JCI37432DS1

W. Haque, I. Shimomura, Y. Matsuzawa, A. Garg, K. Petersen et al., Serum adiponectin and leptin levels in patients with lipodystrophies Disordered lipid metabolism and the pathogenesis of insulin resistance, J Clin Endocrinol Metab Physiol Rev, vol.87, issue.87, pp.507-520, 2002.

K. Szymanski, D. Binns, R. Bartz, N. Grishin, W. Li et al., The lipodystrophy protein seipin is found at endoplasmic reticulum lipid droplet junctions and is important for droplet morphology, Proceedings of the National Academy of Sciences, vol.104, issue.52, pp.20890-20895, 2007.
DOI : 10.1073/pnas.0704154104

J. Magre, Seipin deficiency alters fatty acid Delta9 desaturation and lipid droplet formation in Berardinelli-Seip congenital lipodystrophy, Biochimie, vol.91, pp.796-803, 2009.

A. Agarwal, I. Kazachkova, S. Ten, and A. Garg, Mutation, The Journal of Clinical Endocrinology & Metabolism, vol.93, issue.12, pp.4617-4623, 2008.
DOI : 10.1210/jc.2008-0123

C. Kim, M. Delepine, E. Boutet, E. Mourabit, H. et al., Association of a Homozygous Nonsense Caveolin-1 Mutation with Berardinelli-Seip Congenital Lipodystrophy, The Journal of Clinical Endocrinology & Metabolism, vol.93, issue.4, pp.1129-1134, 2008.
DOI : 10.1210/jc.2007-1328

H. Worman and G. Bonne, ???Laminopathies???: A wide spectrum of human diseases, Experimental Cell Research, vol.313, issue.10, pp.2121-2133, 2007.
DOI : 10.1016/j.yexcr.2007.03.028

C. Vigouroux, J. Magre, M. Vantyghem, C. Bourut, O. Lascols et al., Lamin A/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy, Diabetes, vol.49, issue.11, pp.1958-1962, 2000.
DOI : 10.2337/diabetes.49.11.1958

C. Vigouroux, M. Auclair, E. Dubosclard, M. Pouchelet, J. Capeau et al., Nuclear envelope disorganization in fibroblasts from lipodystrophic patients with heterozygous R482Q/W mutations in the lamin A/C gene, J Cell Sci, vol.114, pp.4459-4468, 2001.

L. Azzi, M. Vantyghem, J. Capeau, and C. Vigouroux, Adipose tissue of lipodystrophic patients carry mutations of the lamina A/C has fibrotic changes and mitochondrial alterations in the absence of inflammation, Diabetes Metab, vol.35, pp.27-27, 2009.

M. Vantyghem, P. Pigny, C. Maurage, N. Rouaix-emery, T. Stojkovic et al., R482W Mutation Show Muscular and Cardiac Abnormalities, The Journal of Clinical Endocrinology & Metabolism, vol.89, issue.11, pp.5337-5346, 2004.
DOI : 10.1210/jc.2003-031658

T. Dechat, K. Pfleghaar, K. Sengupta, T. Shimi, D. Shumaker et al., Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatin, Genes & Development, vol.22, issue.7, pp.832-853, 2008.
DOI : 10.1101/gad.1652708

P. Scaffidi and T. Misteli, Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing, Nature Cell Biology, vol.157, issue.4, pp.452-459, 2008.
DOI : 10.1016/j.ab.2004.02.002

M. Caron, M. Auclair, B. Donadille, V. Bereziat, B. Guerci et al., Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with prelamin A accumulation, oxidative stress and premature cellular senescence, Cell Death and Differentiation, vol.20, issue.10, pp.1759-1767, 2007.
DOI : 10.1006/excr.2000.4823

D. Savage, G. Tan, C. Acerini, S. Jebb, M. Agostini et al., Human Metabolic Syndrome Resulting From Dominant-Negative Mutations in the Nuclear Receptor Peroxisome Proliferator-Activated Receptor-??, Diabetes, vol.52, issue.4, pp.910-917, 2003.
DOI : 10.2337/diabetes.52.4.910

S. George, J. Rochford, C. Wolfrum, S. Gray, S. Schinner et al., A Family with Severe Insulin Resistance and Diabetes Due to a Mutation in AKT2, Science, vol.304, issue.5675, pp.1325-1328, 2004.
DOI : 10.1126/science.1096706

D. Savage, R. Semple, M. Clatworthy, P. Lyons, B. Morgan et al., Complement Abnormalities in Acquired Lipodystrophy Revisited, The Journal of Clinical Endocrinology & Metabolism, vol.94, issue.1, pp.10-161396, 2002.
DOI : 10.1210/jc.2008-1703

M. Gougeon, L. Penicaud, B. Fromenty, P. Leclercq, J. Viard et al., Adipocytes targets and actors in the pathogenesis of HIV-associated lipodystrophy and metabolic alterations, Antivir Ther, vol.9, pp.161-177, 2004.
URL : https://hal.archives-ouvertes.fr/hal-00409144

C. Lagathu, M. Kim, M. Maachi, C. Vigouroux, P. Cervera et al., HIV antiretroviral treatment alters adipokine expression and insulin sensitivity of adipose tissue in vitro and in vivo, Biochimie, vol.87, issue.1, pp.65-71, 2005.
DOI : 10.1016/j.biochi.2004.12.007

C. Lagathu, B. Eustace, M. Prot, D. Frantz, Y. Gu et al., Some HIV antiretrovirals increase oxidative stress and alter chemokine, cytokine or adiponectin production in human adipocytes and macrophages, Antivir Ther, vol.12, pp.489-500, 2007.

C. Vatier, S. Leroyer, J. Quette, N. Brunel, J. Capeau et al., HIV protease inhibitors differently affect human subcutaneous and visceral fat: they induce IL-6 production and alter lipid storage capacity in subcutaneous but not visceral adipose tissue explants, Antiviral Therapy, vol.13, pp.15-16, 2008.

M. Caron, M. Auclairt, A. Vissian, C. Vigouroux, and J. Capeau, Contribution of mitochondrial dysfunction and oxidative stress to cellular premature senescence induced by antiretroviral thymidine analogues, Antivir Ther, vol.13, pp.27-38, 2008.

M. Kim, P. Leclercq, E. Lanoy, P. Cervera, B. Antuna-puente et al., A 6-month interruption of antiretroviral therapy improves adipose tissue function in HIV-infected patients: the ANRS EP29 Lipostop Study, Antivir Ther, vol.12, pp.1273-1283, 2007.

T. Maurin, C. Saillan-barreau, B. Cousin, L. Casteilla, A. Doglio et al., Tumor necrosis factor-?? stimulates HIV-1 production in primary culture of human adipocytes, Experimental Cell Research, vol.304, issue.2, pp.544-551, 2005.
DOI : 10.1016/j.yexcr.2004.12.003

M. Giralt, P. Domingo, F. Villarroya, J. Brown, J. Kohler et al., HIV-1 Infection and the PPARgamma-Dependent Control of Adipose Tissue Physiology HIV-1 activates macrophages independent of Toll-like receptors, PPAR Res PLoS ONE, vol.3, pp.607902-607939, 2008.

E. Arioglu, J. Duncan-morin, N. Sebring, K. Rother, N. Gottlieb et al., Efficacy and Safety of Troglitazone in the Treatment of Lipodystrophy Syndromes, Annals of Internal Medicine, vol.133, issue.4, pp.263-274, 2000.
DOI : 10.7326/0003-4819-133-4-200008150-00009

L. Slama, E. Lanoy, M. Valantin, J. Bastard, A. Chermak et al., Effect of pioglitazone on HIV-1-related lipodystrophy: a randomized double-blind placebocontrolled trial (ANRS 113) Leptin-replacement therapy for lipodystrophy, Antivir Ther N Engl J Med, vol.13, issue.346, pp.67-76570, 2002.